McMichael Bryan J
SEC insider (Form 3/4/5 filer). CIK 0001944868. Chief Financial Officer at Coherus Oncology, Inc. (CHRS). 18 reported Form 4/5 transactions since Sep 2024; latest on May 29, 2026. Located in REDWOOD CITY, CA.
Companies McMichael Bryan J has filed insider reports for
- Coherus Oncology, Inc. (CHRS): Officer, Chief Financial Officer
McMichael Bryan J
CIK: 0001944868
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Coherus Oncology, Inc.
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- May 29, 2026CHRS
Coherus Oncology, Inc.
AwardDirectStock Option (Right to Buy)
25K shares- - May 29, 2026CHRS
Coherus Oncology, Inc.
AwardDirectStock Option (Right to Buy)
30K shares- - May 29, 2026CHRS
Coherus Oncology, Inc.
AwardDirectStock Option (Right to Buy)
25K shares- - May 29, 2026CHRS
Coherus Oncology, Inc.
AwardDirectStock Option (Right to Buy)
15K shares- - May 29, 2026CHRS
Coherus Oncology, Inc.
AwardDirectStock Option (Right to Buy)
25K shares- - May 29, 2026CHRS
Coherus Oncology, Inc.
DispositionDirectStock Option (Right to Buy)
100K shares- - May 29, 2026CHRS
Coherus Oncology, Inc.
DispositionDirectStock Option (Right to Buy)
25K shares- - May 29, 2026CHRS
Coherus Oncology, Inc.
DispositionDirectStock Option (Right to Buy)
15K shares- - May 29, 2026CHRS
Coherus Oncology, Inc.
DispositionDirectStock Option (Right to Buy)
25K shares- - May 29, 2026CHRS
Coherus Oncology, Inc.
DispositionDirectStock Option (Right to Buy)
25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Award Stock Option (Right to Buy) | 25,000 | - | - | Direct |
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Award Stock Option (Right to Buy) | 30,000 | - | - | Direct |
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Award Stock Option (Right to Buy) | 25,000 | - | - | Direct |
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Award Stock Option (Right to Buy) | 15,000 | - | - | Direct |
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Award Stock Option (Right to Buy) | 25,000 | - | - | Direct |
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Disposition Stock Option (Right to Buy) | 100,000 | - | - | Direct |
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Disposition Stock Option (Right to Buy) | 25,000 | - | - | Direct |
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Disposition Stock Option (Right to Buy) | 15,000 | - | - | Direct |
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Disposition Stock Option (Right to Buy) | 25,000 | - | - | Direct |
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Disposition Stock Option (Right to Buy) | 25,000 | - | - | Direct |
1-10 of 18 transactions